
Pfizer COVID-19 pill could cut severe illness by 89%, company says
Fox News
Pfizer Inc. announced Friday that its pill to treat novel COVID-19 was found to reduce the risk of hospitalization or death by 89% among high-risk adult patients in a clinical trial.
Similar reductions in COVID-19-related hospitalization or death were observed in patients – who were unvaccinated with mild to moderate symptoms – treated within five days of symptom onset.
Few details were reported on side effects but Pfizer said rates of problems were similar between the two groups at about 20%.
More Related News

Students return to Brown University amid questions over security policies that enabled mass shooting
Brown University shooting survivors return to campus as students voice safety concerns following deadly attack by Claudio Manuel Neves-Valente that killed two students.












